These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 33862490)
41. Phage Therapy Takes on Broad Applications. Mertz L IEEE Pulse; 2022; 13(5):9-15. PubMed ID: 36301810 [TBL] [Abstract][Full Text] [Related]
42. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies. Liu D; Van Belleghem JD; de Vries CR; Burgener E; Chen Q; Manasherob R; Aronson JR; Amanatullah DF; Tamma PD; Suh GA Viruses; 2021 Jun; 13(7):. PubMed ID: 34209836 [TBL] [Abstract][Full Text] [Related]
43. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection. Shariati A; Noei M; Chegini Z J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167 [TBL] [Abstract][Full Text] [Related]
44. Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy. Marongiu L; Burkard M; Lauer UM; Hoelzle LE; Venturelli S Clin Microbiol Rev; 2022 Dec; 35(4):e0006222. PubMed ID: 36069758 [TBL] [Abstract][Full Text] [Related]
45. Ameliorating the antimicrobial resistance crisis: phage therapy. Saha D; Mukherjee R IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079 [TBL] [Abstract][Full Text] [Related]
46. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Segall AM; Roach DR; Strathdee SA Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502 [TBL] [Abstract][Full Text] [Related]
47. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy. Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610 [TBL] [Abstract][Full Text] [Related]
49. Phage therapy for severe bacterial infections: a narrative review. Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298 [TBL] [Abstract][Full Text] [Related]
50. [Summary of the conference "Phages and phage therapy: from Félix d'Hérelle to 2.0 phages"]. Defresne T Virologie (Montrouge); 2023 Aug; 27(4):219-224. PubMed ID: 37565677 [TBL] [Abstract][Full Text] [Related]
52. Animal Models to Translate Phage Therapy to Human Medicine. Brix A; Cafora M; Aureli M; Pistocchi A Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466194 [TBL] [Abstract][Full Text] [Related]
53. Manufacturing of bacteriophages for therapeutic applications. João J; Lampreia J; Prazeres DMF; Azevedo AM Biotechnol Adv; 2021; 49():107758. PubMed ID: 33895333 [TBL] [Abstract][Full Text] [Related]
54. A century of phage therapy: from novel discoveries about the past to the challenges of the today. Bach-Rojecky L; Lacković Z Pharmazie; 2021 Oct; 76(10):519-521. PubMed ID: 34620283 [TBL] [Abstract][Full Text] [Related]
55. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation. Faltus T Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808 [TBL] [Abstract][Full Text] [Related]
57. Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine. Vlassov VV; Tikunova NV; Morozova VV Biochemistry (Mosc); 2020 Nov; 85(11):1350-1361. PubMed ID: 33280578 [TBL] [Abstract][Full Text] [Related]
58. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback? Hill C; Mills S; Ross RP Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526 [TBL] [Abstract][Full Text] [Related]